Latest Turnaround Strategies News

Bapcor Limited has obtained unanimous lender approval to temporarily ease its Net Leverage Ratio covenant, supporting its ongoing turnaround efforts through mid-2026.

Wellnex Life reports encouraging early results from its turnaround strategy, posting a modest EBITDA profit and robust sales growth for its Pain Away brand.

Bapcor Limited has revised its first-half FY26 guidance to a statutory net loss, citing weaker trade segment performance and one-off costs, while maintaining a cautiously optimistic full-year outlook supported by cost savings and leadership changes.

JAYRIDE Group Limited has raised $935,000 through a share placement and convertible notes, signaling strong shareholder confidence as it advances toward ASX reinstatement and regional SaaS growth.

Metroglass has reported a 5% revenue decline in its half-year results but achieved a significant reduction in net debt and improved profitability, signaling progress in its turnaround strategy amid challenging market conditions.

Saferoads Holdings has divested its Road Safety Rentals business for $10.8 million, repaid debt, and is now focusing on rebuilding its core product sales with new hires and product innovation.

Pure Foods Tasmania reported a $1 million operating cash outflow in the September quarter due to restructuring and timing factors but anticipates positive cash flow and growth driven by new Coles product launches and operational efficiencies.

Oldfields Holdings navigated a challenging first quarter of FY2026 with tight cash flow and subdued sales but made strategic moves to streamline operations and bolster scaffold order backlogs for growth.

KNeoMedia reports significant progress toward ASX reinstatement, driven by strategic capital raises and the expansion of its KneoScience platform into New York high schools, boosting potential revenue and student reach.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

Bapcor reports a 2.7% revenue decline in 1Q26 and outlines a comprehensive operational review and cost-saving plan, setting cautious guidance for FY26.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.